TABLE OF CONTENTS
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF NORTH AMERICA ECLINICAL SOLUTIONS MARKET
1.4 LIMITATIONS
1.5 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 NORTH AMERICA ECLINICAL SOLUTIONS MARKET: GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 CURRENCY AND PRICING
2.5 DBMR TRIPOD DATA VALIDATION MODEL
2.6 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.7 DBMR MARKET POSITION GRID
2.8 MULTIVARIATE MODELING
2.9 PRODUCTS LIFELINE CURVE
2.10 SECONDARY SOURCES
2.11 ASSUMPTIONS
3 MARKET OVERVIEW
3.1 DRIVERS
3.1.1 INCREASING ADOPTION OF CLINICAL TRIALS
3.1.2 RISING GOVERNMENT INITIATIVES
3.1.3 GROWING NUMBER OF CONTRACT RESEARCH ORGANIZATION
3.1.4 INCREASE IN R & D EXPENDITURE BY PHARMACEUTICAL AND BIOPHARMACEUTICAL COMPANIES
3.2 RESTRAINTS
3.2.1 DEARTH OF TRAINED PROFESSIONALS
3.2.2 HIGH IMPLEMENTATION COST
3.3 OPPORTUNITIES
3.3.1 STRATEGIC INITIATIVES BY MARKET PLAYERS
3.3.2 TECHNOLOGICAL ADVANCEMENT
3.4 CHALLENGES
3.4.1 STRINGENT REGULATIONS
4 EXECUTIVE SUMMARY
5 PREMIUM INSIGHTS
6 NORTH AMERICA ECLINICAL SOLUTIONS MARKET, BY PRODUCT
6.1 OVERVIEW
6.2 ELECTRONIC DATA CAPTURE (EDC) AND CLINICAL DATA MANAGEMENT SYSTEMS (CDMS)
6.3 RANDOMIZATION AND TRIAL SUPPLY MANAGEMENT (RTSM)
6.4 CLINICAL TRIAL MANAGEMENT SYSTEMS (CTMS)
6.5 ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA)
6.6 ELECTRONIC TRIAL MASTER FILE SYSTEM
6.7 SAFETY SOLUTIONS
6.8 REGULATORY INFORMATION MANAGEMENT SOLUTIONS
6.9 CLINICAL DATA INTEGRATION PLATFORMS
6.10 CLINICAL ANALYTICS PLATFORMS
6.11 OTHER ECLINICAL SOLUTIONS
7 NORTH AMERICA ECLINICAL SOLUTIONS MARKET, BY DEPLOYMENT TYPE
7.1 OVERVIEW
7.2 WEB-HOSTED (ON-DEMAND) SOLUTIONS
7.3 CLOUD-BASED (SAAS) SOLUTIONS
7.4 LICENSED ENTERPRISE (ON-PREMISE) SOLUTIONS
8 NORTH AMERICA ECLINICAL SOLUTIONS MARKET, BY CLINICAL TRIAL PHASE
8.1 OVERVIEW
8.2 PHASE III
8.3 PHASE II
8.4 PHASE IV
8.5 PHASE I
9 NORTH AMERICA ECLINICAL SOLUTIONSMARKET, BY END USER
9.1 OVERVIEW
9.2 HOSPITALS/HEALTHCARE PROVIDERS
9.3 CONTRACT RESEARCH ORGANIZATIONS (CROS)
9.4 ACADEMIC INSTITUTES
9.5 PHARMA & BIOTECH ORGANIZATIONS
9.6 MEDICAL DEVICE MANUFACTURERS
9.7 CONSULTING SERVICE COMPANIES
?
10 NORTH AMERICA ECLINICAL SOLUTIONS MARKET, BY GEOGRAPHY
10.1 NORTH AMERICA
10.1.1 U.S.
10.1.2 CANADA
10.1.3 MEXICO
11 NORTH AMERICA ECLINICAL SOLUTIONS MARKET, COMPANY LANDSCAPE
11.1 COMPANY SHARE ANALYSIS: NORTH AMERICA
12 COMPANY PROFILE
12.1 ORACLE
12.1.1 COMPANY SNAPSHOT
12.1.2 REVENUE ANALYSIS
12.1.3 COMPANY SHARE ANALYSIS
12.1.4 PRODUCT PORTFOLIO
12.1.5 RECENT DEVELOPMENTS
12.2 MEDIDATA SOLUTIONS
12.2.1 COMPANY SNAPSHOT
12.2.2 REVENUE ANALYSIS
12.2.3 COMPANY SHARE ANALYSIS
12.2.4 PRODUCT PORTFOLIO
12.2.5 RECENT DEVELOPMENT
12.3 PAREXEL INTERNATIONAL CORPORATION
12.3.1 COMPANY SNAPSHOT
12.3.2 COMPANY SHARE ANALYSIS
12.3.3 PRODUCT PORTFOLIO
12.3.4 RECENT DEVELOPMENTS
12.4 BIOCLINICA
12.4.1 COMPANY SNAPSHOT
12.4.2 PRODUCT PORTFOLIO
12.4.3 RECENT DEVELOPMENTS
12.5 ERT CLINICAL
12.5.1 COMPANY SNAPSHOT
12.5.2 PRODUCT PORTFOLIO
12.5.3 RECENT DEVELOPMENTS
12.6 ARIS NORTH AMERICA
12.6.1 COMPANY SNAPSHOT
12.6.2 PRODUCT PORTFOLIO
12.6.3 RECENT DEVELOPMENTS
?
12.7 ADVARRA
12.7.1 COMPANY SNAPSHOT
12.7.2 PRODUCT PORTFOLIO
12.7.3 RECENT DEVELOPMENTS
12.8 ANJU SOFTWARE
12.8.1 COMPANY SNAPSHOT
12.8.2 PRODUCT PORTFOLIO
12.8.3 RECENT DEVELOPMENTS
12.9 BIO-OPTRONICS, INC
12.9.1 COMPANY SNAPSHOT
12.9.2 PRODUCT PORTFOLIO
12.9.3 RECENT DEVELOPMENTS
12.10 DATATRAK INT.
12.10.1 COMPANY SNAPSHOT
12.10.2 REVENUE ANALYSIS
12.10.3 SOLUTION PORTFOLIO
12.10.4 RECENT DEVELOPMENTS
12.11 ECLINICALWORKS
12.11.1 COMPANY SNAPSHOT
12.11.2 PRODUCT PORTFOLIO
12.11.3 RECENT DEVELOPMENTS
12.12 ECLINICAL SOLUTIONS LLC
12.12.1 COMPANY SNAPSHOT
12.12.2 PRODUCT PORTFOLIO
12.12.3 RECENT DEVELOPMENTS
12.13 IBM CORPORATION
12.13.1 COMPANY SNAPSHOT
12.13.2 REVENUE ANALYSIS
12.13.3 PRODUCT PORTFOLIO
12.13.4 RECENT DEVELOPMENT
12.14 ICON PLC
12.14.1 COMPANY SNAPSHOT
12.14.2 REVENUE ANALYSIS
12.14.3 SERVICE PORTFOLIO
12.14.4 RECENT DEVELOPMENTS
12.15 MASTERCONTROL, INC.
12.15.1 COMPANY SNAPSHOT
12.15.2 SOLUTION PORTFOLIO
12.15.3 RECENT DEVELOPMENTS
?
12.16 MAXISIT
12.16.1 COMPANY SNAPSHOT
12.16.2 PRODUCT PORTFOLIO
12.16.3 RECENT DEVELOPMENT
12.17 OMNICOMM SYSTEMS, INC
12.17.1 COMPANY SNAPSHOT
12.17.2 REVENUE ANALYSIS
12.17.3 PRODUCT PORTFOLIO
12.17.4 RECENT DEVELOPMENTS
12.18 RESONANCE HEALTH
12.18.1 COMPANY SNAPSHOT
12.18.2 REVENUE ANALYSIS
12.18.3 PRODUCT PORTFOLIO
12.18.4 RECENT DEVELOPMENTS
12.19 REALTIME
12.19.1 COMPANY SNAPSHOT
12.19.2 PRODUCT PORTFOLIO
12.19.3 RECENT DEVELOPMENT
12.20 SIGNANT HEALTH
12.20.1 COMPANY SNAPSHOT
12.20.2 SOLUTION PORTFOLIO
12.20.3 RECENT DEVELOPMENTS
12.21 VEEVA SYSTEMS
12.21.1 COMPANY SNAPSHOT
12.21.2 REVENUE ANALYSIS
12.21.3 COMPANY SHARE ANALYSIS
12.21.4 PRODUCT PORTFOLIO
12.21.5 RECENT DEVELOPMENT
12.22 XYBION CORPORATION
12.22.1 COMPANY SNAPSHOT
12.22.2 PRODUCT PORTFOLIO
12.22.3 RECENT DEVELOPMENTS
13 QUESTIONNAIRE
14 RELATED REPORTS